Trial Profile
Evaluation of effect of rivaroxaban on resolution of left atrial / left atrial appendage thrombus in patients with non-valvular atrial fibrillation
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Jan 2018
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- 23 Jan 2018 Status changed from recruiting to completed.
- 23 Jan 2015 New trial record